Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,550 across all filing types
Latest filing 2026-04-28 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Please find enclosed a copy of the Unaudited Financial Results for the Quarter ended 31st March 2026
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement from Sanofi India Limited dated April 28, 2026, reporting the outcome of a Board Meeting. It includes approval of unaudited financial results for the quarter ended March 31, 2026, along with a Limited Review Report by Price Waterhouse & Co Chartered Accountants LLP. The document also details changes in the Board of Directors, including completion of tenure of some independent directors and appointment of a new Chairman, as well as reconstitution of various Board Committees. The document contains the unaudited financial results with substantive financial data and analysis for the quarter, which is a period shorter than a full fiscal year. The presence of the Limited Review Report and detailed financial tables confirms this is a comprehensive interim/quarterly financial report. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2026-04-28 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 100% confidence The document is a detailed announcement from Sanofi India Limited dated April 28, 2026, reporting the outcome of a Board Meeting. It includes approval of unaudited financial results for the quarter ended March 31, 2026, along with a Limited Review Report by Price Waterhouse & Co Chartered Accountants LLP. The document contains extensive financial data including revenue, expenses, profit, and other comprehensive income for the quarter, as well as management commentary and committee re-constitutions. The presence of unaudited quarterly financial results with detailed financial statements and a review report indicates this is an Interim / Quarterly Report. The document is not merely an announcement of a report but contains substantive financial data and analysis. Therefore, the correct classification is Interim / Quarterly Report (IR).
2026-04-28 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a formal disclosure letter addressed to stock exchanges (BSE and NSE) regarding an order issued by a tax authority (Assistant Commissioner - Central Goods & Service Tax). It references compliance with Regulation 30 of the SEBI (LODR) Regulations, which pertains to disclosure of material events. The content details a refund order related to tax matters and the company's intention to appeal a partial non-grant of refund. The document is a regulatory announcement about a specific event affecting the company, not a financial report, earnings release, or management discussion. It is also short (3298 characters) and serves as a disclosure under listing obligations. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance disclosures that do not fit other specific categories.
2026-04-21 English
Kindy refer the attachment
Regulatory Filings Classification · 95% confidence The document is a formal disclosure letter addressed to stock exchanges (BSE and NSE) regarding an order issued by a tax authority (Assistant Commissioner - Central Goods & Service Tax). It references compliance with Regulation 30 of the SEBI (LODR) Regulations, which pertains to disclosure of material events. The content details a refund order related to tax matters and the company's intention to appeal a partial non-grant of refund. The document is short (3298 characters) and serves as a regulatory disclosure of a material event rather than a financial report or earnings release. It does not contain financial statements, management discussion, or audit information. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance disclosures that do not fit other specific categories.
2026-04-21 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2026-04-20 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about an upcoming Board of Directors meeting scheduled to consider and approve the unaudited financial results for the quarter ended 31st March 2026. It also mentions the closure of the trading window related to the publication of these results. The document is brief (1816 characters) and serves as an announcement rather than containing the financial results or detailed report itself. It is a regulatory announcement about a board meeting and financial results approval, not the financial report or earnings release itself. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2026-04-20 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.